Knowledge of Living Will in Patients With Rheumatic Diseases
Study Details
Study Description
Brief Summary
The living will is a legal document derived from a communication and deliberation process, medical ethical aspect, currently regulated in Mexico by the General Health Law and the Health Law of Mexico City.
Knowledge of living will in the population with chronic diseases, including rheumatic diseases, has been little addressed. Most patients do not know what the living will document is, so they do not carry it out and others, despite knowing it, have a passive attitude toward doing it.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
A study will be carried out on patients with rheumatic diseases and healthy family controls. Patients will be selected from those attending the Department of Immunology and Rheumatology in Mexico City outpatient department, including consecutive cases.
The patients will be assessed for their quality of life and disability. Patients and controls will be evaluated on the knowledge of living will, their perceptions about specific health outcomes, sociodemographic characteristics, comorbidities, and psychiatric pathology.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Cases Patients with rheumatic diseases from the outpatient clinic at a tertiary care level in Mexico City |
Other: Health Assessment Questionnaire (HAQ)
The HAQ is based on five patient-centered dimensions: disability, pain, medication effects, costs of care, and mortality
Other: Depression, Anxiety and Stress Scale (DASS-21)
DASS-21 is a set of three self-report scales designed to measure the emotional states of depression, anxiety, and stress. Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content
Other: Brief Resilient Coping Scale
Brief Resilient Coping Scale is a 4-item measure designed to capture tendencies to cope with stress in a highly adaptive manner
Other: WHOQOL-BREF
WHOQOL-BREF is a 26-item instrument consisting of four domains: physical health, psychological health, social relationships, and environmental health; it also contains QOL and general health items
Other: Routine assessment of patient index data 3 (RAPID-3)
RAPID- 3 measures: function, pain, and patient global estimate of status. Each of the 3 individual measures is scored 0 to 10, for a total of 30
Other: Rheumatic disease comorbidity index
It is rated from 0 to 9 and comprises 11 comorbid conditions including lung disease, cardio-vascular disease, hypertension, diabetes, fracture, depression, cancer, and gastrointestinal ulcer
Other: Living will questionnaire
A questionnaire with 17 items about knowledge of the living will.
Other: Perceptions of Health Outcomes Questionnaire
A questionnaire with 7 items about the probability of quitting the job, getting an infectious disease, requiring emergency medical attention, hospitalization or intensive care, dependence and death.
|
Controls Two patients´ relatives of the same sex, age ± five years and who are known to be healthy |
Other: Health Assessment Questionnaire (HAQ)
The HAQ is based on five patient-centered dimensions: disability, pain, medication effects, costs of care, and mortality
Other: Depression, Anxiety and Stress Scale (DASS-21)
DASS-21 is a set of three self-report scales designed to measure the emotional states of depression, anxiety, and stress. Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content
Other: Brief Resilient Coping Scale
Brief Resilient Coping Scale is a 4-item measure designed to capture tendencies to cope with stress in a highly adaptive manner
Other: WHOQOL-BREF
WHOQOL-BREF is a 26-item instrument consisting of four domains: physical health, psychological health, social relationships, and environmental health; it also contains QOL and general health items
Other: Rheumatic disease comorbidity index
It is rated from 0 to 9 and comprises 11 comorbid conditions including lung disease, cardio-vascular disease, hypertension, diabetes, fracture, depression, cancer, and gastrointestinal ulcer
Other: Living will questionnaire
A questionnaire with 17 items about knowledge of the living will.
Other: Perceptions of Health Outcomes Questionnaire
A questionnaire with 7 items about the probability of quitting the job, getting an infectious disease, requiring emergency medical attention, hospitalization or intensive care, dependence and death.
|
Outcome Measures
Primary Outcome Measures
- Knowledge of the living will with the living will questionnaire (locally development) [1 day At study inclusion (After their rheumatology consultation)]
To evaluate the knowledge of the living will, using the living will questionnaire (locally development), among the patients with rheumatic diseases and healthy controls.
- Perceptions of Health Outcomes with the perceptions of health outcomes questionnaire (locally development) [1 day At study inclusion (After their rheumatology consultation)]
To evaluate the perceptions of the of health outcomes using the perceptions of health outcomes questionnaire (locally development), among the patients with rheumatic diseases and healthy controls
Eligibility Criteria
Criteria
Inclusion Criteria:
Cases
-
Patients with a rheumatic disease diagnostic by a rheumatologist
-
Patients with rheumatic diseases attending the Department of Immunology and Rheumatology in Mexico City outpatient department
-
Patients who agree to participate in the study, who complete and sign the informed consent Controls
-
Relative of a patient with rheumatic diseases of the same sex and age ± 5 years, without known rheumatic and/or chronic disease and without the use of pharmacological treatment for more than 7 days during the month before study entry.
Exclusion Criteria:
Cases
- Patients with severe diseases or in palliative care by a rheumatologist
Controls
- Withdrawal of the study
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Investigators
- Principal Investigator: Virginia Pascual-Ramos, Dr., National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRE-4312